Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 394 (NASDAQ: $NEPT)
(TSX: $NEPT.TO) (TSXV: $RLV.V) (TSX: $WEED.TO) (NYSE: $CGC)
Delta, Kelowna, BC, April 3, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at http://www.investorideas.com/news/2020/cannabis-potcasts/04031NEPT-RLV-WEED-CGC.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we are looking at a few public announcements.
Neptune Wellness
Solutions Inc. (NASDAQ:
NEPT) (TSX:
NEPT) announced that it
has received Health Canada authorization to commercialize natural, plant-based
hand sanitizer products. The Company has also engaged with the National
Research Council of Canada (NRC), Canada's largest federal research and
development organization, to support NRC's efforts to facilitate the
development, manufacturing and ultimately commercialization of solutions to
meet COVID-19 related needs.
Neptune
will leverage its product formulation expertise to develop natural, plant-based
sanitizers that effectively kills 99.9% of germs and bacteria, made with a
specialized blend of essential oils and fruit extract. The product will be formulated at the
Company's production and processing facilities in Sherbrooke, Quebec and
Conover, North Carolina, and also with the help of its contract manufacturing
partners.
Following
its assessment of Neptune's plant-based hand sanitizer products, deeming it as
safe and effective in killing bacteria and germs and of high quality, Health
Canada issued Neptune a product license and Natural Product Number (NPN), which
will appear on the product label to inform customers that the product has been
reviewed and approved by Health Canada.
In
an effort to supply the North American demand of hand sanitizer products, the
Company is also working to fast track FDA registration to produce and market
OTC hand sanitizer formulations and products out of its Conover, North Carolina
facility.
Neptune
is currently sourcing new supply of raw material inputs to ensure ample product
supply at launch, which is expected in Summer 2020. Neptune intends to sell its
hand sanitizer formulations to consumer-packaged goods (CPG) brands as well as
retailers seeking private label owned brands to offer to their customers in the
U.S. and Canada. The Company also plans to supply the U.S. and Canadian
governments and healthcare systems with sanitizer products through both direct
and indirect channels.
"We
are very pleased to receive Health Canada authorization to bring our
plant-based hand sanitizer to market as we believe consumers will increasingly
look for natural sanitizers as their use of these products become more regular
in light of COVID-19," said Michael Cammarata, Chief Executive Officer of
Neptune. "Neptune's entrance into
the hand sanitizer market reflects our ability to be nimble and quickly meet
strong market demand for effective, natural and safe household health and
wellness products. Our procurement and sales teams are working in concert with
our scientists and engineers to source high quality raw materials in order to
ramp up production and bring our products to market as quickly as
possible."
Relevium
Technologies Inc. (TSX.V:
RLV)
(OTCQB:
RLLVF) announced that it
has sourced and will begin commercializing a line of Bioganix® hand sanitizers.
Relevium
is leveraging its strong network of suppliers and formulators to manufacture
and bring to market a line of hand sanitizers under the Bioganix ® Cleancare.
The Company will have an initial format of 8oz (235ml) that will effectively
kill 99.9% of germs and bacteria. The product is formulated and manufactured in
Miami, Florida at the Company's specialty products contract manufacturing
partner and will be sold both online and through selected retail chains in the
US.
Relevium
expect to receive its first production batch in about 8 weeks
"The
impact of the COVID-19 pandemic will go beyond the immediate socio-economic
state of emergency and we believe we will see the rise of new social
interaction practices, which will become the norm. We are pleased to position
Bioganix® Cleancare as part of this new norm and become a household must amongst our current and future customers" said
Aurelio Useche, Chief Executive Officer of Relevium.
Storz & Bickel announced that
Health Canada has issued a Medical Device Licence for the new Volcano Medic 2
(License No.: 103842), an advanced cannabis vapourizer device for medical use.
This licence permits distribution to medical institutions, clinics, and
patients in Canada – including distribution through Spectrum Therapeutics, the
medical cannabis division of Canopy
Growth Corporation (TSX:
WEED) (NYSE:
CGC).
The device is currently available for purchase on Spectrum Therapeutics, Storz
& Bickel's online shop, and various medical cannabis clinics across Canada.
Storz
& Bickel is known for their long history of high quality vapourizer
manufacturing and they were the first company to manufacture
medically-certified cannabis vapourizers, including the iconic original Volcano
Medic.
The
Volcano Medic 2, which has been approved for medical use in Europe, Australia,
and now Canada, includes improved features for patients such as tenfold faster
heat up times, an alternative tubular (direct-to-mouth) inhalation method in
addition to the standard Valve Balloon, and an intuitive touch display that
allows patients to set their desired temperature directly on the device.
Patients can expect the same high-quality materials, impeccable craftsmanship,
and unparalleled safe and combustion-free vaporization experience they've
become accustomed to with all Storz & Bickel devices with the new
reinvented Volcano Medic 2. Alongside their medically approved cannabis
vapourizers, Storz & Bickel is known for manufacturing non-medical
vapourizers in accordance with international technical safety standards,
ensuring premium quality for each component part.
Due
to its classification as a licensed medical device, the Volcano Medic 2 is
eligible for tax deduction benefits in Canada or cost reimbursements by health
insurance companies in Germany, similar to its predecessor and the Mighty
Medic.
"Storz
and Bickel is internationally-known for its best-in-class device design and
manufacturing," said Dr. Mark Ware, Chief Medical Officer, Canopy Growth.
"This license will allow us to offer even more options for patients who
may be interested in vapourizing whole-flower dried cannabis as an alternative
method of medicating."
In
the past 12 months, Storz & Bickel updated several products in their
existing portfolio, adding new features, improvements, and adjustments designed
to increase user and patient experience, including the new Volcano Hybrid that
was released in June and the Crafty+ that launched in November.
Senators
in Mexico asked the
Supreme Court March 27 to extend an April 30 deadline for lawmakers to draft a
bill to legalize and regulate cannabis for medical, adult and industrial uses,
according to a Cannabis Wire
report.
Both
the Senate and the Supreme Court have suspended many legislative procedures
until at least mid-April due to the COVID-19 outbreak, Cannabis Wire reported, and many lawmakers have indicated that this
will cause them to miss deadlines to pass certain bills, including the cannabis
legislation.
Sen.
Patricia Mercado told Cannabis Wire
that the suspension of the Supreme Court will likely mean a deadline extension
on the cannabis bill, and said the deadline should be extended to May 30 to
align with how long Supreme Court activities are suspended.
However,
she added there may be a chance that the Supreme Court could deem the Senate as
an essential activity and mandate that lawmakers must meet the April 30
deadline.
In
that case, Mercado told Cannabis Wire
that the senators would hold electronic meetings to finalize the bill, which
would then be sent to the Chamber of Deputies, Mexico’s lower house of Congress,
for approval.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration
Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
